Genome-wide association study identifies five new schizophrenia loci Nature genetics 43 (10), 969-976, 2011 | 2068 | 2011 |
Suicide risk in schizophrenia: learning from the past to change the future M Pompili, XF Amador, P Girardi, J Harkavy-Friedman, M Harrow, ... Annals of general psychiatry 6, 1-22, 2007 | 525 | 2007 |
Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naive schizophrenia patients J Nielsen, S Skadhede, CU Correll Neuropsychopharmacology 35 (9), 1997-2004, 2010 | 284 | 2010 |
Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? J Nielsen, CU Correll, P Manu, JM Kane The Journal of clinical psychiatry 74 (6), 20799, 2013 | 279 | 2013 |
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis B Galling, A Roldan, K Hagi, L Rietschel, F Walyzada, W Zheng, XL Cao, ... World Psychiatry 16 (1), 77-89, 2017 | 276 | 2017 |
Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis B Galling, A Roldan, RE Nielsen, J Nielsen, T Gerhard, M Carbon, ... JAMA psychiatry 73 (3), 247-259, 2016 | 258 | 2016 |
Psychiatrists’ attitude towards and knowledge of clozapine treatment J Nielsen, M Dahm, H Lublin, D Taylor Journal of psychopharmacology 24 (7), 965-971, 2010 | 252 | 2010 |
Safety and tolerability of antipsychotic polypharmacy JA Gallego, J Nielsen, M De Hert, JM Kane, CU Correll Expert opinion on drug safety 11 (4), 527-542, 2012 | 226 | 2012 |
An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Pharmacopsychiatry 55 (02), 73-86, 2022 | 222 | 2022 |
Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine-or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical … JR Larsen, L Vedtofte, MSL Jakobsen, HR Jespersen, MI Jakobsen, ... JAMA psychiatry 74 (7), 719-728, 2017 | 207 | 2017 |
The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good P Uggerby, SD Østergaard, R Røge, CU Correll, J Nielsen Dan Med J 60 (2), A4578, 2013 | 196 | 2013 |
Optimizing clozapine treatment J Nielsen, P Damkier, H Lublin, D Taylor Acta Psychiatrica Scandinavica 123 (6), 411-422, 2011 | 196 | 2011 |
Worldwide differences in regulations of clozapine use J Nielsen, C Young, P Ifteni, T Kishimoto, YT Xiang, PFJ Schulte, ... CNS drugs 30 (2), 149-161, 2016 | 187 | 2016 |
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles JI Goldstein, L Fredrik Jarskog, C Hilliard, A Alfirevic, L Duncan, ... Nature communications 5 (1), 4757, 2014 | 187 | 2014 |
Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? R Røge, BK Møller, CR Andersen, CU Correll, J Nielsen Schizophrenia research 140 (1-3), 204-213, 2012 | 182 | 2012 |
Assessing QT interval prolongation and its associated risks with antipsychotics J Nielsen, C Graff, JK Kanters, E Toft, D Taylor, JM Meyer CNS drugs 25, 473-490, 2011 | 181 | 2011 |
Consensus statement on the use of clozapine during the COVID-19 pandemic D Siskind, WG Honer, S Clark, CU Correll, A Hasan, O Howes, JM Kane, ... Journal of Psychiatry and Neuroscience 45 (3), 222-223, 2020 | 174 | 2020 |
Abuse potential of pregabalin: a systematic review O Schjerning, M Rosenzweig, A Pottegård, P Damkier, J Nielsen CNS drugs 30, 9-25, 2016 | 173 | 2016 |
Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management S Fanoe, D Kristensen, A Fink-Jensen, HK Jensen, E Toft, J Nielsen, ... European heart journal 35 (20), 1306-1315, 2014 | 172 | 2014 |
Risk factors for ileus in patients with schizophrenia J Nielsen, JM Meyer Schizophrenia bulletin 38 (3), 592-598, 2012 | 170 | 2012 |